We Are One Seven »

Relmada Therapeutics shares owned by We Are One Seven

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by We Are One Seven from 13F filings

Historical chart of We Are One Seven investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by We Are One Seven consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by We Are One Seven

Quarter filed Position value Share count Share price at filing
2023-12-31 $414k 100k 4.14
2023-09-30 $300k 100k 3.00
2023-06-30 $246k 100k 2.46

More positions owned by We Are One Seven

Apple Put Option (AAPL)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Ishares Tr Msci Intl Qualty (IQLT)
Select Sector Spdr Tr Financial (XLF)
Amazon (AMZN)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
JPMorgan Chase & Co. (JPM)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Innovator Etfs Tr Us Eqt Ultra Bf (UAUG)

View all positions for We Are One Seven

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Franklin Resources
BlackRock
Millennium Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Bank of America Corporation
Marshall Wace
Bridgeway Capital Management

View all funds holding Relmada Therapeutics